Opharmic Technology

Hong Kong, Hong Kong · Founded 2016 · Privately Held (backing)

Manufacturer of ultrasound-mediated technologies intended and devices designed to provide non-invasive ocular drug delivery for a variety of eye diseases and conditions. Opharmic Technology is based in Hong Kong, Hong Kong and was founded in 2016.

Last price · $/share
—
Implied valuation
—
Total raised
—
Last round
—
Valuation — not yet established

No valuation for Opharmic Technology is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised and the funding record below are the closest available signals.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Opharmic Technology with a free account
  • ·Watch Opharmic Technology: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Opharmic Technology funding history

No rounds on record

No funding rounds for Opharmic Technology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

How Opharmic Technology's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Opharmic Technology, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →